Echinacea purpurea

Echinacea purpurea is a North American native plant containing phenolic compounds, particularly cichoric acid at concentrations of 63.66-70.31 mg/g in extracts. Current clinical research has not established documented health benefits, with studies primarily focusing on phytochemical analysis and extraction methods.

Origin & History

Echinacea purpurea is a perennial herbaceous plant native to eastern and central North America, belonging to the Asteraceae family, commonly known as purple coneflower. The whole plant (roots, leaves, flowers, and stems) is used to produce extracts through methods including supercritical CO2 extraction with ethanol entrainer (60-80%) or hydroalcoholic maceration using 40-75% ethanol solutions.

Historical & Cultural Context

The available research does not detail historical or traditional medicinal uses of Echinacea purpurea. References are limited to modern extraction techniques without cultural or historical context.

Health Benefits

• No clinical evidence for health benefits found in available research
• Research focuses solely on extraction methods and phytochemical analysis
• Contains phenolic compounds including cichoric acid (63.66-70.31 mg/g in extracts)
• Traditional use claims not documented in provided research
• Further clinical research needed to establish health benefits

How It Works

Echinacea purpurea's primary bioactive compound, cichoric acid, is a phenolic compound that may interact with cellular antioxidant pathways. The specific molecular mechanisms remain unclear due to limited clinical research focusing primarily on phytochemical identification rather than biological activity studies.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Echinacea purpurea were found in the available research. The provided sources focus exclusively on extraction methods and phytochemical analysis, with no PMIDs or clinical outcomes reported.

Clinical Summary

Current research on Echinacea purpurea focuses exclusively on extraction methods and phytochemical analysis rather than clinical efficacy studies. No clinical trials demonstrating health benefits were found in available research literature. Studies have successfully quantified phenolic compounds, particularly cichoric acid concentrations in various extracts. Further clinical investigation is needed to establish any therapeutic applications beyond traditional use claims.

Nutritional Profile

Echinacea purpurea is not consumed as a conventional food source, so traditional macronutrient profiling (fats, carbohydrates, protein as dietary contributors) is not clinically established. Bioactive compound data is the primary nutritional focus. Phenolic compounds are the most documented constituents: cichoric acid (a caffeic acid derivative) is the dominant polyphenol, measured at 63.66–70.31 mg/g in concentrated extracts, and serves as a key quality marker for the plant. Additional phenolics include echinacoside, chlorogenic acid, and caffeic acid derivatives, though precise concentrations vary by plant part (aerial parts vs. roots), extraction solvent (ethanol, methanol, water), and growing conditions. Alkylamides (isobutylamides) are lipophilic bioactive compounds concentrated in roots, known for contributing to the characteristic tingling sensation; quantitative data in available research is limited. Polysaccharides (arabinogalactans, heteroxylans) are present in aerial parts and roots and are considered immunomodulatory candidates in in vitro studies, though concentrations are not specified in current data. Flavonoids including rutin and quercetin glycosides are present in minor amounts. Volatile essential oils occur in trace quantities. Bioavailability: phenolic absorption is moderate and dependent on gut microbiota metabolism; alkylamides show relatively high oral bioavailability due to lipophilic nature. No significant dietary vitamins or minerals have been quantified in available research.

Preparation & Dosage

No clinically studied dosage ranges are available from the research provided. Standardization to cichoric acid content (63.66-70.31 mg/g) is mentioned only in extraction contexts, not for clinical dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified in available research

Safety & Interactions

Safety data for Echinacea purpurea supplements is limited due to lack of comprehensive clinical studies. Potential allergic reactions may occur, particularly in individuals sensitive to plants in the Asteraceae family. Drug interactions and contraindications have not been well-documented in clinical literature. Pregnant and breastfeeding women should consult healthcare providers before use due to insufficient safety data.